Immucell Cp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | ICCC | MYO | HUGE | ||
Company | Immucell Cp | Myomo Inc | Fsd Pharma Inc Cl B | ||
Price Information | |||||
Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
Open | 7.11 | 11.73 | 2.00 | ||
High | 7.40 | 11.82 | 2.02 | ||
Low | 7.11 | 10.76 | 1.78 | ||
Last | 7.40 | 11.83 | 1.96 | ||
Change | -0.13 | -0.54 | -0.25 | ||
% Change | -1.73% | -4.37% | -11.31% | ||
Volume | 5,285 | 156,908 | 1,093,132 | ||
20-Day Average Volume | 23,339 | 204,294 | 790,307 | ||
Previous Close | 7.53 | 12.37 | 2.21 | ||
Industry | Medical Products | Medical Products | Medical Products | ||
Has Options | No | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 6.49 | 9.14 | 1.97 | ||
20-Day Raw Stochastic | 86.07% | 65.34% | 40.77% | ||
20-Day Relative Strength | 66.27% | 69.40% | 49.47% | ||
Weighted Alpha | +53.48 | +146.55 | -74.41 | ||
Today's Opinion | 100% Buy | 100% Buy | 64% Sell | ||
Previous Opinion | 100% Buy | 100% Buy | 24% Sell | ||
Last Month's Opinion | 100% Buy | 88% Buy | 56% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +6.47% since 01/20/21 | +4.74% since 01/20/21 | -16.11% since 01/20/21 | ||
Low | 6.70 on 01/22/21 | 10.13 on 01/21/21 | 1.78 on 01/27/21 | ||
High | 7.68 on 01/26/21 | 13.89 on 01/26/21 | 2.38 on 01/21/21 | ||
1-Month | |||||
%Chg | +18.40% since 12/24/20 | +62.54% since 12/24/20 | +13.67% since 12/24/20 | ||
Low | 5.67 on 12/30/20 | 6.36 on 12/31/20 | 1.55 on 12/30/20 | ||
High | 7.68 on 01/26/21 | 13.89 on 01/26/21 | 2.46 on 01/20/21 | ||
3-Month | |||||
%Chg | +37.37% since 10/27/20 | +155.78% since 10/27/20 | +9.15% since 10/27/20 | ||
Low | 5.21 on 11/02/20 | 4.30 on 10/28/20 | 1.28 on 11/13/20 | ||
High | 7.68 on 01/26/21 | 13.89 on 01/26/21 | 2.46 on 01/20/21 | ||
6-Month | |||||
%Chg | +28.70% since 07/27/20 | +190.72% since 07/27/20 | -49.05% since 07/27/20 | ||
Low | 4.98 on 07/31/20 | 3.46 on 09/04/20 | 1.28 on 11/13/20 | ||
High | 7.68 on 01/26/21 | 13.89 on 01/26/21 | 6.87 on 07/30/20 | ||
Key Statistics | |||||
Market Capitalization, $K | 54,313 | 56,677 | 42,348 | ||
Shares Outstanding, K | 7,213 | 4,582 | 19,162 | ||
Annual Sales | 13,720,000 | 3,840,000 | 190,000 | ||
Annual Net Income | -1,300,000 | -10,710,000 | -39,200,000 | ||
Last Quarter Sales | 3,720,000 | 1,930,000 | N/A | ||
Last Quarter Net Income | -320,000 | -2,780,000 | N/A | ||
60-Month Beta | 1.14 | 1.62 | 1.39 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | N/A | N/A | ||
Latest Earnings Date | 02/23/21 | 03/11/21 | 03/02/21 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |